| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
a Department of Physiology and Reproductive Sciences Program, University of Michigan, Ann Arbor, Michigan 48109
During the estrous cycle, secretion of prolactin is largely restricted to a surge on proestrus. We investigated whether this proestrous prolactin surge initiates regression of the corpora lutea of the preceding cycle. Adult rats were killed prior to the prolactin surge (Proestrus group), following the prolactin surge (Estrus group), after chemical blockade of the prolactin surge with bromocryptine (Estrus+BRC group), and after blockade of the prolactin surge and administration of prolactin (Estrus+BRC+PRL group). Corpora lutea of the current (proestrus) or preceding (estrus) cycle were dissected out, weighed, and sectioned for immunohistochemistry or cultured for examination of in vitro progestin production. Numbers of luteal monocytes/macrophages, differentiated macrophages, and apoptotic nuclei per high-power field were greater for Estrus and Estrus+BRC+PRL than for Estrus+BRC, which in turn had greater numbers than Proestrus (P < 0.05). In contrast, BRC completely reversed the decline in luteal weight observed between Proestrus and Estrus (P < 0.05). Number of major histocompatibility complex II-positive cells was not different between groups (P > 0.05). Finally, progestin production by corpora lutea in vitro was lower for Proestrus than for the other groups (P < 0.05). The results indicate that the prolactin surge alone is not responsible for initiation of apoptosis or immune cell infiltration in regressing corpora lutea of the estrous cycle, although prolactin increases these markers of regression. Prolactin does cause a decline in luteal weight; however, the corpora lutea retain the capacity for steroidogenesis. We conclude that although prolactin has a role in luteal regression, it is not solely responsible for the initiation of this process.
2 Correspondence: J.M. Bowen, Department of Physiology, University of Michigan, 7627 Medical Sciences II Building, Ann Arbor, MI 48109-0622. FAX: 734 936 8813; bowenjm{at}umich.edu
This article has been cited by other articles:
|
|
 |
|
  M. J Cannon, J. S Davis, and J. L Pate The class II major histocompatibility complex molecule BoLA-DR is expressed by endothelial cells of the bovine corpus luteum Reproduction, May 1, 2007; 133(5): 991 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takiguchi, N. Sugino, K. Esato, A. Karube-Harada, A. Sakata, Y. Nakamura, H. Ishikawa, and H. Kato Differential Regulation of Apoptosis in the Corpus Luteum of Pregnancy and Newly Formed Corpus Luteum after Parturition in Rats Biol Reprod, February 1, 2004; 70(2): 313 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nagaosa, A. Shiratsuchi, and Y. Nakanishi Determination of Cell Type Specificity and Estrous Cycle Dependency of Monocyte Chemoattractant Protein-1 Expression in Corpora Lutea of Normally Cycling Rats in Relation to Apoptosis and Monocyte/Macrophage Accumulation Biol Reprod, November 1, 2002; 67(5): 1502 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gaytan, C. Bellido, C. Morales, and J.E. Sanchez-Criado Luteolytic Effect of Prolactin Is Dependent on the Degree of Differentiation of Luteal Cells in the Rat Biol Reprod, August 1, 2001; 65(2): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Simpson, M. J. Byers, and T. E. Curry Jr. Spatiotemporal Messenger Ribonucleic Acid Expression of Ovarian Tissue Inhibitors of Metalloproteinases throughout the Rat Estrous Cycle Endocrinology, May 1, 2001; 142(5): 2058 - 2069. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Bowen and P. L. Keyes Repeated Exposure to Prolactin Is Required to Induce Luteal Regression in the Hypophysectomized Rat Biol Reprod, April 1, 2000; 63(4): 1179 - 1184. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
